-
1
-
-
71549169890
-
Extended-spectrum beta-lacta- mase-producing organisms
-
Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lacta- mase-producing organisms. J Hosp Infect. 2009;73:345-54.
-
(2009)
J Hosp Infect
, vol.73
, pp. 345-354
-
-
Falagas, M.E.1
Karageorgopoulos, D.E.2
-
2
-
-
39049128343
-
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: An emerging public-health concern
-
Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159-66.
-
(2008)
Lancet Infect Dis
, vol.8
, pp. 159-166
-
-
Pitout, J.D.1
Laupland, K.B.2
-
3
-
-
43249098135
-
Treatment of recurrent urosepsis with tigecycline: A pharmacological perspective
-
Curcio D. Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective. J Clin Microbiol. 2008;46:1892-3.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 1892-1893
-
-
Curcio, D.1
-
4
-
-
0025678424
-
Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly
-
Ferraro G, Ambrosi G, Bucci L, Palmieri R, Palmieri G. Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly. Chemotherapy. 1990;36 Suppl 1:46-49.
-
(1990)
Chemotherapy
, vol.36
, Issue.SUPPL. 1
, pp. 46-49
-
-
Ferraro, G.1
Ambrosi, G.2
Bucci, L.3
Palmieri, R.4
Palmieri, G.5
-
5
-
-
33845668975
-
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections
-
Pullukcu H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemir S, Ulusoy S. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimi-crob Agents. 2007;29:62-5.
-
(2007)
Int J Antimi-crob Agents
, vol.29
, pp. 62-65
-
-
Pullukcu, H.1
Tasbakan, M.2
Sipahi, O.R.3
Yamazhan, T.4
Aydemir, S.5
Ulusoy, S.6
-
6
-
-
79952199427
-
Management of complicated urinary tract infections in the era of antimicrobial resistance
-
Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2010;122:7-15.
-
(2010)
Postgrad Med
, vol.122
, pp. 7-15
-
-
Bader, M.S.1
Hawboldt, J.2
Brooks, A.3
-
7
-
-
85038508407
-
-
updated 7/2010, Last accessed 2/11/2011
-
Tigecycline Prescribing and Label Information. 2011 [updated 7/2010]; Available from: http://www.accessdata.fda.gov/drugsatfda_docs/Iabel/2010/021821s021lbl.pdf. Last accessed 2/11/2011.
-
(2011)
Tigecycline Prescribing and Label Information
-
-
-
8
-
-
52649112236
-
Community infections caused by extended-spectrum beta-lacta mase-producing Escherichia coli
-
Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum beta-lacta mase-producing Escherichia coli. Arch Intern Med. 2008;168:1897-902.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1897-1902
-
-
Rodriguez-Bano, J.1
Alcala, J.C.2
Cisneros, J.M.3
Grill, F.4
Oliver, A.5
Horcajada, J.P.6
-
9
-
-
42549159206
-
Antimicrobial susceptibility of mul- tidrug-resistant Gram negative bacteria to fosfomycin
-
Falagas ME, Kanellopoulou MD, Karageorgopoulos DE, Dimopoulos G, Rafailidis PI, Skarmoutsou ND, et al. Antimicrobial susceptibility of mul- tidrug-resistant Gram negative bacteria to fosfomycin. Eur J Clin Microbiol Infect Dis. 2008;27:439-43.
-
(2008)
Eur J Clin Microbiol Infect Dis
, vol.27
, pp. 439-443
-
-
Falagas, M.E.1
Kanellopoulou, M.D.2
Karageorgopoulos, D.E.3
Dimopoulos, G.4
Rafailidis, P.I.5
Skarmoutsou, N.D.6
-
10
-
-
34547468409
-
Rapid devel opment of Acinetobacter baumannii resistance to tigecycline
-
Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM. Rapid devel opment of Acinetobacter baumannii resistance to tigecycline. Pharma cotherapy. 2007;27:1198-201.
-
(2007)
Pharma Cotherapy
, vol.27
, pp. 1198-1201
-
-
Reid, G.E.1
Grim, S.A.2
Aldeza, C.A.3
Janda, W.M.4
Clark, N.M.5
-
11
-
-
38949216726
-
Treatment with tigecycline of recurrent urosepsis caused by extended- spectrum-beta-lactamase-producing Escherichia coli
-
Krueger WA, Kempf VA, Peiffer M, Nagele U, Unertl KE, Schroeder TH. Treatment with tigecycline of recurrent urosepsis caused by extended- spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol. 2008;46:817-20.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 817-820
-
-
Krueger, W.A.1
Kempf, V.A.2
Peiffer, M.3
Nagele, U.4
Unertl, K.E.5
Schroeder, T.H.6
-
12
-
-
77955602606
-
Successful treat ment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
-
Geerlings SE, Donselaar-vander Pant KA, Keur I. Successful treat ment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother. 2010;65:2048-9.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 2048-2049
-
-
Geerlings, S.E.1
van der Donselaar-Pant, K.A.2
Keur, I.3
-
13
-
-
50249156755
-
Tigecycline for the treatment of Acineto bacter infections: A case series
-
Gallagher JC, Rouse HM. Tigecycline for the treatment of Acineto bacter infections: a case series. Ann Pharmacother. 2008;42:1188-94.
-
(2008)
Ann Pharmacother
, vol.42
, pp. 1188-1194
-
-
Gallagher, J.C.1
Rouse, H.M.2
-
14
-
-
38949189555
-
Single daily high-dose tigecy cline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and En terobacter aerogenes nosocomial urinary tract infection
-
Cunha BA, McDermott B, Nausheen S. Single daily high-dose tigecy cline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and En terobacter aerogenes nosocomial urinary tract infection. J Chemother. 2007;19:753-4.
-
(2007)
J Chemother
, vol.19
, pp. 753-754
-
-
Cunha, B.A.1
McDermott, B.2
Nausheen, S.3
-
15
-
-
77953578904
-
Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation
-
Nix DE, Matthias KR. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation. J Antimicrob Chemother. 2010;65:1311-2.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1311-1312
-
-
Nix, D.E.1
Matthias, K.R.2
|